Neurotrophic activities and therapeutic experience with a brain derived peptide preparation.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Journal of neural transmission. Supplementum

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-7091-6467-9_25PMID 9700665
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic results with Cerebrolysin in the treatment of dementia.

  1997cited by this paper
• P.4.006 Efficacy of cerebrolysin in alzheimer's disease

  1997cited by this paper
• Comparison between huperzine A, tacrine, and E2020 on cholinergic transmission at mouse neuromuscular junction in vitro.

  1997cited by this paper
• 2-07-06 In vivo administration of brain-derived peptides increases the transport of glucose from blood to brain

  1997cited by this paper
• Blood flow velocity changes in the middle cerebral artery as an index of the chronicity of hypertension.

  1997cited by this paper
• Trk neurotrophin receptors in cholinergic neurons of patients with Alzheimer's disease.

  1997cited by this paper
• Nerve growth factor and nootropic drug Cerebrolysin but not fibroblast growth factor can reduce spatial memory impairment elicited by fimbria-fornix transection: short-term study.

  1996cited by this paper
• Alzheimer's disease : biology, diagnosis, and therapeutics

  1996cited by this paper
• Effects of two protein-free peptide derivatives on passive avoidance behaviour of 24-month-old rats.

  1996cited by this paper
• Therapeutic potential of neurotrophic factors for neurological disorders

  1996cited by this paper
• Regional specificity of alterations in NGF, BDNF and NT‐3 levels in Alzheimer's disease

  1996cited by this paper
• Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative Cerebrolysin.

  1996cited by this paper
• Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene.

  1996cited by this paper
• The influence of Cerebrolysin and E021 on spatial navigation of young rats.

  1996cited by this paper
• The long-term effect of NGF, b-FGF and Cerebrolysin on the spatial memory after fimbria-fornix lesion in rats.

  1996cited by this paper
• Induction of HSP-70 after hyperosmotic opening of the blood-brain barrier in the rat.

  1995cited by this paper
• Brain-derived peptides regulate the steady state levels and increase stability of the blood-brain barrier GLUT1 glucose transporter mRNA.

  1995cited by this paper
• The efficacy of cholinergic drugs in patients with Alzheimer's disease—focus on the aminoacridines

  1995cited by this paper
• Neurodegeneration in the central nervous system of apoE-deficient mice.

  1995cited by this paper
• Efficacy of the peptidergic nootropic drug cerebrolysin in patients with senile dementia of the Alzheimer type (SDAT).

  1994cited by this paper
• Neurotrophic growth factors and neurodegenerative diseases: therapeutic potential of the neurotrophins and ciliary neurotrophic factor.

  1994cited by this paper
• Efficacy of Cerebrolysin® in Alzheimer’s disease

  1994cited by this paper
• Neurotrophic mechanisms and neuronal degeneration

  1993cited by this paper
• Regulation of hippocampal muscarinic receptor function by chronic nerve growth factor treatment in adult rats with fimbrial transections.

  1993cited by this paper
• Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy.

  1993cited by this paper
• Nerve growth factor affects11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (Case Report)

  1992cited by this paper
• Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report).

  1992cited by this paper
• Neurotrophic factor-like effect of FPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain.

  1992cited by this paper
• The effects of cerebrolysin® on survival and sprouting of neurons from cerebral hemispheres and from the brainstem of chicken embryos in vitro

  1992cited by this paper
• Emerging pharmacology of nerve growth factor.

  1991cited by this paper
• A multidimensional approach in testing nootropic drug effects (Cerebrolysin).

  1990cited by this paper
• Trophic factors and neuronal survival.

  1989cited by this paper
• [The effect of amino acids on the in-vitro differentiation of hippocampal neurons-morphometric and electron microscopic studies on ribosomes, protein synthesis and synaptogenesis].

  1977cited by this paper
• [Effects of brain extract and hydrolysate on nerve tissue in vitro].

  1975cited by this paper

• Strategies for blood-brain barrier rejuvenation and repair.

  2026cites this paper
• Neuroprotection by Cerebrolysin and Citicoline Through the Upregulation of Brain-Derived Neurotrophic Factor (BDNF) Expression in the Affected Neural Cells: A Preliminary Clue Obtained Through an In Vitro Study

  2024cites this paper
• Current neuroprotective agents in stroke

  2024cites this paper
• Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide.

  2021cites this paper
• Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes

  2021cites this paper
• Animal-derived medicinal products in Russia: Current nomenclature and specific aspects of quality control.

  2019cites this paper
• Cerebrolysin for vascular dementia.

  2019cites this paper
• New Therapies for the Treatment of Spastic Cerebral Palsy

  2019cites this paper
• The Use of Piracetam and Cerebrolysin in the Treatment of Agenesis of Corpus Callosum with Colpocephaly

  2019cites this paper
• Cerebrolysin attenuates ethanol-induced spatial memory impairments through inhibition of hippocampal oxidative stress and apoptotic cell death in rats.

  2019cites this paper
• Bioactivity-Guided Isolation of Neuritogenic Factor from the Seeds of the Gac Plant (Momordica cochinchinensis)

  2018influential citation
• Neurochemical alterations after exposure to malathion and neuroprotective potential of cerebrolysin as therapeutic agent against malathion toxicity in rats

  2018cites this paper
• Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease

  2017cites this paper
• Hemispheric Peculiarities of Cerebrolysin Effects on the Brain Functional State in Patients with Atherothrombotic Ischemic Stroke

  2017cites this paper
• Comparative Dynamics of EEG Parameters in Elderly Patients with Depression during Monotherapy and Combined Treatment

  2017cites this paper
• [Comparative dynamics of EEG parameters in elderly depressive patients during monotherapy and combined therapy].

  2016cites this paper
• Mechanisms, treatment and prevention of cellular injury and death from delayed events after aneurysmal subarachnoid hemorrhage

  2014cites this paper
• Biomarqueurs salivaires spécifiques pour la détection de risques, le diagnostic précoce, le pronostic et la surveillance de la maladie d'alzheimer et de la maladie de parkinson

  2013cites this paper
• Cerebrolysin for vascular dementia (Review)

  2013cites this paper
• Cerebrolysin Ameloriates Cognitive Deficits in Type III Diabetic Rats

  2013cites this paper
• Cerebrolysin for vascular dementia.

  2013cites this paper
• Involvement of phospholipase C-γ in the pro-survival role of glial cell line-derived neurotrophic factor in developing motoneurons in rat spinal cords.

  2012cites this paper
• Neuroprotective Effect against Alzheimer's Disease of Porcine Brain Extract

  2012cites this paper
• Regional Comparison of the Neurogenic Effects of CNTF-Derived Peptides and Cerebrolysin in AβPP Transgenic Mice

  2011cites this paper
• Cerebroprotein in Neuropsychiatric Disorders (A Clinical Review)

  2011cites this paper
• Does neurotrophic factor benefit to PD therapy via co-function with ubiquitin-proteasome system?

  2011cites this paper
• Beneficial effects of a neurotrophic peptidergic mixture persist for a prolonged period following treatment interruption in a transgenic model of Alzheimer's disease

  2011cites this paper
• Potential of Preventive Treatment of Alzheimer’s Disease: Results of a Three-Year Prospective Open Comparative Trial of the Efficacy and Safety of Courses of Treatment with Cerebrolysin and Cavinton in Elderly Patients with Mild Cognitive Impairment Syndrome

  2011cites this paper
• Rescue of Synaptic Failure and Alleviation of Learning and Memory Impairments in a Trisomic Mouse Model of Down Syndrome

  2011cites this paper
• Clinical analysis on neuroprotection of transient ischemic attacks

  2011cites this paper
• Cerebrolysin reduces blood‐cerebrospinal fluid barrier permeability change, brain pathology, and functional deficits following traumatic brain injury in the rat

  2010cites this paper
• Rôle des ADAM dans le processus physiopathologique de la maladie d'Alzheimer

  2010cites this paper
• Pharmacologic reversal of neurogenic and neuroplastic abnormalities and cognitive impairments without affecting Aβ and tau pathologies in 3xTg-AD mice

  2010cites this paper
• Neurotrophic peptides incorporating adamantane improve learning and memory, promote neurogenesis and synaptic plasticity in mice

  2010cites this paper
• Neuroprotective and consequent neurorehabilitative clinical outcomes, in patients treated with the pleiotropic drug cerebrolysin

  2009cites this paper
• [Neuroplasticity: main mechanisms and their clinical significance].

  2009cites this paper
• Strategies to promote differentiation of newborn neurons into mature functional cells in Alzheimer brain.

  2009cites this paper
• Recovery following anterior thalamic lesions.

  2009cites this paper
• [Cerebrolysin treatment of mild cognitive impairment of vascular genesis].

  2007cites this paper
• Induction of Neurotrophic Factors GDNF and BDNF Associated with the Mechanism of Neurorescue Action of Rasagiline and Ladostigil

  2007cites this paper
• [Clinical and pharmacoeconomic peculiarities of the treatment with cerebrolysin in the period of rehabilitation of is ischemic stroke.].

  2007cites this paper
• Neuroprotection of Cerebrolysin in tissue culture models of brain ischemia: post lesion application indicates a wide therapeutic window

  2006cites this paper
• A peptide preparation protects cells in organotypic brain slices against cell death after glutamate intoxication

  2005cites this paper
• Two Peptidergic Drugs Increase the Synaptophysin Immunoreactivity in Brains of 24-month-old Rats

  2004cites this paper
• Reinnervation of the rat musculocutaneous nerve stump after its direct reconnection with the C5 spinal cord segment by the nerve graft following avulsion of the ventral spinal roots: a comparison of intrathecal administration of brain-derived neurotrophic factor and Cerebrolysin

  2004cites this paper
• Cerebrolysin inhibits lipid peroxidation induced by insulin hypoglycemia in the brain and heart of mice.

  2003cites this paper
• 6‐Formylpterin protects retinal neurons from transient ischemia–reperfusion injury in rats: A morphological and immunohistochemical study

  2003cites this paper
• Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study

  2003cites this paper
• Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study.

  2003cites this paper
• Ciliary neurotrophic factor (CNTF) affects the excitable and contractile properties of innervated skeletal muscles.

  2003cites this paper
• Cerebrolysin for Alzheimer's disease

  2002cites this paper
• In vitro models of brain ischemia: The peptidergic drug cerebrolysin protects cultured chick cortical neurons from cell death

  2002cites this paper
• Neuroprotection in schizophrenia - What does it mean? - What means do we have?

  2002cites this paper
• Converting a peptide into a drug: strategies to improve stability and bioavailability.

  2002cites this paper
• Erythropoietin – a novel concept for neuroprotection

  2001cites this paper
• Enfermedad de Alzheimer. Presente terapéutico y retos futuros (segunda parte)

  2001cites this paper
• Antiapoptotic effects of the peptidergic drug Cerebrolysin on primary cultures of embryonic chick cortical neurons

  2001cites this paper
• Cerebrolysin therapy in Rett syndrome: clinical and EEG mapping study.

  2001cites this paper
• Effects of Cerebrolysin on the outgrowth and protection of processes of cultured brain neurons

  2001cites this paper
• Increased Density of Glutamate Receptor Subunit 1 Due to Cerebrolysin Treatment: An Immunohistochemical Study on Aged Rats

  2001cites this paper
• Neuroprotection – what does it mean? – what means do we have?

  2001cites this paper
• A brain derived peptide preparation reduces the translation dependent loss of a cytoskeletal protein in primary cultured chicken neurons.

  2000cites this paper
• The Drug Cerebrolysin and its Peptide Fraction E021 Increase the Abundance of the Blood–brain Barrier GLUT1 Glucose Transporter in Brains of Young and Old Rats

  2000cites this paper
• Sustained improvements in patients with dementia of Alzheimer's type (DAT) 6 months after termination of Cerebrolysin therapy

  2000cites this paper
• Oestrogen and nerve growth factor – neuroprotection and repair in Alzheimer’s disease

  2000cites this paper
• Inhibitory effect of a brain derived peptide preparation on the Ca++-dependent protease, calpain

  2000cites this paper
• Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection.

  2000cites this paper
• Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics.

  2000cites this paper
• Approach towards an integrative drug treatment of Alzheimer's disease.

  2000cites this paper
• Apoptosis modulators in the therapy of neurodegenerative diseases

  2000cites this paper
• The Hippocampus: Anatomy, Pathophysiology, and Regenerative Capacity

  2000cites this paper
• Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects.

  2000cites this paper
• Advances in Dementia Research

  2000cites this paper
• Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures.

  1999cites this paper
• Two Peptidergic Drugs Increase the Synaptophysin Immunoreactivity in Brains of 6-week-old Rats

  1999cites this paper